Questionnaire reveals gaps in dantrolene availability and management of malignant hyperthermia in Saudi Arabia, indicating urgent need for improved protocols.
Key Points
Only 18.4% of anesthesiologists reported encounters with suspected malignant hyperthermia patients.
Over 64% of respondents had six or more dantrolene vials available, suggesting varying preparedness.
Survey responses highlighted a pressing need for a dedicated malignant hyperthermia management system in hospitals.
Current low reporting of malignant hyperthermia cases underscores the importance of establishing accurate databases.